Elsevier to integrate NCCN guidelines into Via Oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Elsevier will integrate the National Comprehensive Cancer Network’s Clinical Practice Guidelines in Oncology and utilize the NCCN Chemotherapy Order Templates as a reference into Via Oncology’s Via Portal to provide clinical decision support at point of care and NCCN Guidelines concordance reporting.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login